Pharma Foods International Co., Ltd.
Stock Price Chart
2026/10/09 19:27 UpdatedPrice Trend
2026/10/09 19:27 UpdatedPrice & Trading Details
2026/10/09 19:27 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E
|
167.9K | 0.00% | |
|
iShares Trust-iShares International Small-Cap Equity Factor ETF
|
72.8K | 0.00% | |
|
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF
|
13.9K | +2.21% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
8.5K | +1.00% | |
|
Dimensional ETF Trust-Dimensional International Core Equity Market ETF
|
6.9K | +1.00% | |
|
HOTCHKIS & WILEY Fd.S/DE/-Hotchkis and Wiley Intl Small Cap Diversifie
|
2.8K | 0.00% |
Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥25 | 0.0% |
| 2025 | ¥25 | 0.0% |
| 2024 | ¥25 | +13.6% |
| 2023 | ¥22 | +10.0% |
| 2022 | ¥20 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Income Statement | |||
| Revenue | ¥60,185M | ¥68,572M | ¥62,147M |
| Gross Profit | ¥48,108M | ¥55,279M | ¥48,751M |
| Operating Income | ¥1,133M | ¥3,684M | ¥5,215M |
| Pretax Income | ¥1,449M | ¥3,590M | ¥5,096M |
| Net Income | -¥374M | ¥3,081M | ¥3,205M |
| EPS | -¥12.89 | ¥106.70 | - |
| Operating Margin | 1.88% | 5.37% | 8.39% |
| Balance Sheet | |||
| Total Assets | ¥31,159M | ¥36,232M | ¥36,573M |
| Total Equity | ¥7,070M | ¥9,630M | ¥11,585M |
| Total Liabilities | ¥24,089M | ¥26,602M | ¥24,988M |
| Cash | ¥8,845M | ¥16,306M | ¥15,666M |
| Interest-bearing Debt | ¥16,857M | ¥20,096M | ¥16,891M |
| Equity Ratio | 22.69% | 26.58% | 31.68% |
| D/E Ratio | 2.38 | 2.09 | 1.46 |
| Cash Flow | |||
| Operating CF | -¥6,065M | ¥6,125M | ¥5,486M |
| Investing CF | -¥2,539M | -¥1,013M | -¥1,390M |
| Financing CF | ¥7,679M | ¥2,341M | -¥4,842M |
| Free CF | -¥6,537M | ¥5,720M | ¥4,513M |
| Efficiency | |||
| ROE | -5.29% | 31.99% | 27.67% |
| ROA | -1.20% | 8.50% | 8.76% |
Latest IR Information
-
Notice of Acquisition of Shares (Subsidiarization of Marin Profoods)
Under its medium-term management plan, the Group positions M&A at the core of its growth strategy and resolved at the Board of Directors meeting on 2026-10-06 to acquire shares of Marin Profoods and make it a subsidiary. The acquisition price...
Read more -
Fiscal Year End Supplementary Materials for the Year Ended July 2026
For the fiscal year ended July 2026, the company implemented growth investments in the first half and shifted to profitability in the second half. Operating income increased 11.2% year-over-year, and net income attributable to owners of parent rose 439% year-over-year....
Read more -
(Correction / Numerical data correction) About partial corrections to the Financial Summary for the 2026 July Term (IFRS) [Consolidated]
Partial correction of the 2026 July term Financial Summary has been disclosed. The corrected parts are in the consolidated balance sheet and main notes on page 9 of the attached materials. The reason for the correction is that an error...
Read more -
Consolidated Financial Summary for the Fiscal Year Ending July 2026 (Japanese GAAP)
Sales of 63,223 million yen, year-over-year change of △3.1%. Operating income 2,632 million yen (up 11.2%), Ordinary income 2,440 million yen (△4.4%), Net income attributable to owners of the parent 1,988 million yen (up 439.1%). Full-year projections: sales 64,000 million...
Read more
Latest News (5 items)
Company Information
About
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory. The company was founded in 1997 and is headquartered in Kyoto, Japan.
